MRNA241004P95000
- 22.73
- 0.000.00%
Moderna Newsroom
The Covid Era Tech Promises To Reinvent Cancer Treatment
Is Moderna, Inc. (MRNA) the Worst Performing Stock to Buy on the Dip?
Top Movers as S&P 500 Clocks Another Quarter of Growth
Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational MRNA Norovirus Vaccine, MRNA-1403
Express News | Dr. Robert Langer, co-founder of moderna, has joined the scientific advisory board of KLOTHO Neurosciences Company.
Express News | DR. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (Klto)
Moderna Inc (NASDAQ:MRNA): Jim Cramer Is Disappointed
Moderna Enters Green After Six Straight Sessions in Red
Moderna Blamed After Children Offered £1,500 to Take Part in Covid-19 Trial
Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry
Moderna (MRNA) Stock Slides as Market Rises: Facts to Know Before You Trade
Here's How Much $100 Invested In Moderna 5 Years Ago Would Be Worth Today
'Mpox Cases Double In Los Angeles County, Health Officials Urge Vaccination; Los Angeles County Public Health Officials Report Increase, Recommend Prevention Measures' - Pasadena Now
Biden On Sudan Says End This War Now; Let's Move Quickly To Face Mpox Outbreak In Africa
President Biden Will Announce Donation Of 1M MPox Vaccine Doses, At Least $500M To African Countries To Support Their Response To Outbreak
CDC Says No Cases Of Clade IA Mpox Have Been Reported Outside Central African Countries Where Clade IA MPVX Is Endemic
How to Get Free At-Home Covid-19 Tests -- Barrons.com
Top 3 Health Care Stocks That May Explode This Month
Bridgewater Unloads Lilly and Apple Shares -- Barron's
Deutsche Bank Cuts Moderna Price Target to $75 From $80